[HTML][HTML] Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss
Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects
of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public …
of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public …
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Emerging Burden
S Batool, K Morton Cuthrell, N Tzenios… - … Research Journal of …, 2022 - publish7promo.com
Liver is the largest solid organ in the body that performs over 100 functions. It removes the
toxins and waste products from the blood stream, maintains healthy blood sugar levels …
toxins and waste products from the blood stream, maintains healthy blood sugar levels …
Exposure to per-and polyfluoroalkyl substances and markers of liver injury: a systematic review and meta-analysis
Background: Experimental evidence indicates that exposure to certain pollutants is
associated with liver damage. Per-and polyfluoroalkyl substances (PFAS) are persistent …
associated with liver damage. Per-and polyfluoroalkyl substances (PFAS) are persistent …
Statin safety and associated adverse events: a scientific statement from the American Heart Association
CB Newman, D Preiss, JA Tobert… - … , and vascular biology, 2019 - Am Heart Assoc
One in 4 Americans> 40 years of age takes a statin to reduce the risk of myocardial
infarction, ischemic stroke, and other complications of atherosclerotic disease. The most …
infarction, ischemic stroke, and other complications of atherosclerotic disease. The most …
[HTML][HTML] Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of hepatic fat
accumulation after the exclusion of other causes of hepatic steatosis, including other causes …
accumulation after the exclusion of other causes of hepatic steatosis, including other causes …
ACG clinical guideline: evaluation of abnormal liver chemistries
PY Kwo, SM Cohen, JK Lim - … journal of the American College of …, 2017 - journals.lww.com
Clinicians are required to assess abnormal liver chemistries on a daily basis. The most
common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate …
common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate …
Evolution of NAFLD and its management
The global prevalence of nonalcoholic fatty liver disease (NAFLD) is estimated to be 25%
and continues to rise worldwide in the setting of the obesity epidemic. This increase is …
and continues to rise worldwide in the setting of the obesity epidemic. This increase is …
Use of liver imaging and biopsy in clinical practice
Use of Liver Imaging and Biopsy in Clinical Practice | NEJM Skip to main content NEJM Group
Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician …
Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician …
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
H Yki-Järvinen - The lancet Diabetes & endocrinology, 2014 - thelancet.com
Metabolic syndrome is a cluster of metabolic abnormalities that identifies people at risk of
diabetes and cardiovascular disease, whereas non-alcoholic fatty liver disease (NAFLD) is …
diabetes and cardiovascular disease, whereas non-alcoholic fatty liver disease (NAFLD) is …
The global NAFLD epidemic
NAFLD is a clinical syndrome characterized by predominant macrovesicular steatosis of the
liver. The clinical and histological phenotypes of NAFLD extend from a nonalcoholic fatty …
liver. The clinical and histological phenotypes of NAFLD extend from a nonalcoholic fatty …